Literature DB >> 29921496

Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.

Fangying Xu1, Si Li2, Jing Zhang2, Lili Wang2, Xuesong Wu2, Jing Wang2, Qiong Huang2, Maode Lai3.   

Abstract

BACKGROUND: Tumor tissues consist of heterogeneous cancer cells and stroma cells, including cancer stem cells and immune cells. Epithelial-mesenchymal transition (EMT) programs closely associate with acquisition of stemness. We investigated for the first time the clinical significance of combining cancer stem cells, immune cells, and EMT traits.
MATERIALS AND METHODS: In 419 colorectal carcinomas, stem-cell markers (Nanog, Lgr5, CD44v6, ALDH1A1), EMT markers (E-cadherin, Snail), and immune-cell markers (CD3+, CD4+ or CD8+ T lymphocytes, CD20+ B lymphocytes, CD68+ macrophages) were detected in tumor center (TC) and tumor invasive front by an immunohistochemical method. Unsupervised hierarchical clustering analysis was performed to group the data according to correlation analyses. Survival analysis and chi-square test were performed to explore the significance of this clustering.
RESULTS: There were correlations among the expression of Nanog, Lgr5, CD44v6, and immune cell counts (P < .05). Nanog, Lgr5, CD44v6, and ALDH1A1 positively related to E-cadherin or Snail (P < .05). A cluster (termed cluster SIE) based on cancer stemness markers (Nanog, Lgr5, CD44v6, ALDH1A1 in TC), EMT markers (E-cadherin, Snail in TC), and immune-cell markers (CD4+ and CD8+ T-lymphocyte counts in TC, and CD68+ macrophages in tumor invasive front) could significantly predict 5-year survival (P = .040). Multivariate Cox proportional hazard model showed that only tumor, node, metastasis classification system stage and cluster SIE were independent prognostic predictors (hazard ratio = 1.920; 95% confidence interval, 1.082-3.407; P = .026).
CONCLUSION: Cancer stemness, immune state, and EMT programs should be considered as a whole. Cluster SIE was an independent predictor for 5-year survival of patients with colorectal cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Epithelial–mesenchymal transition; Immune cells; Prognosis; TNM stage II

Mesh:

Substances:

Year:  2018        PMID: 29921496     DOI: 10.1016/j.clcc.2018.05.007

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  7 in total

1.  Integrative Analysis Revealed Stemness Features and a Novel Stemness-Related Classification in Colorectal Cancer Patients.

Authors:  Meng-Ling Ye; Si-Qi Li; Yi-Xin Yin; Ke-Zhi Li; Ji-Lin Li; Bang-Li Hu
Journal:  Front Cell Dev Biol       Date:  2022-06-03

2.  Inhibiting EMT, stemness and cell cycle involved in baicalin-induced growth inhibition and apoptosis in colorectal cancer cells.

Authors:  Bolin Yang; Huiru Bai; Yunli Sa; Ping Zhu; Ping Liu
Journal:  J Cancer       Date:  2020-02-10       Impact factor: 4.207

3.  Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Authors:  Na Li; Yalin Li; Peixian Zheng; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-21       Impact factor: 5.555

Review 4.  Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.

Authors:  Inese Briede; Dainis Balodis; Janis Gardovskis; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

5.  Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC.

Authors:  Yi Luo; Wei-Bo Xu; Ben Ma; Yu Wang
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

Review 6.  Proteomic Technology "Lens" for Epithelial-Mesenchymal Transition Process Identification in Oncology.

Authors:  Monica Neagu; Carolina Constantin; Marinela Bostan; Constantin Caruntu; Simona Rebeca Ignat; Sorina Dinescu; Marieta Costache
Journal:  Anal Cell Pathol (Amst)       Date:  2019-10-29       Impact factor: 2.916

7.  Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition.

Authors:  Jan Schulte Am Schulte Am Esch; Beatrice Ariane Windmöller; Johannes Hanewinkel; Jonathan Storm; Christine Förster; Ludwig Wilkens; Martin Krüger; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.